- Home
- NRXP vs LVTX Comparison
NRXP vs LVTX Comparison
Compare NRXP & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- LVTX
- Stock Information
- Founded
- NRXP 2015
- LVTX 2016
- Country
- NRXP United States
- LVTX Netherlands
- Employees
- NRXP N/A
- LVTX N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- LVTX Health Care
- Exchange
- NRXP Nasdaq
- LVTX Nasdaq
- Market Cap
- NRXP 32.6M
- LVTX 30.0M
- IPO Year
- NRXP N/A
- LVTX 2021
- Fundamental
- Price
- NRXP $2.09
- LVTX $1.33
- Analyst Decision
- NRXP Strong Buy
- LVTX Hold
- Analyst Count
- NRXP 4
- LVTX 3
- Target Price
- NRXP $28.25
- LVTX $3.17
- AVG Volume (30 Days)
- NRXP 124.9K
- LVTX 58.8K
- Earning Date
- NRXP 05-13-2025
- LVTX 05-20-2025
- Dividend Yield
- NRXP N/A
- LVTX N/A
- EPS Growth
- NRXP N/A
- LVTX N/A
- EPS
- NRXP N/A
- LVTX N/A
- Revenue
- NRXP N/A
- LVTX $11,982,000.00
- Revenue This Year
- NRXP N/A
- LVTX N/A
- Revenue Next Year
- NRXP N/A
- LVTX N/A
- P/E Ratio
- NRXP N/A
- LVTX N/A
- Revenue Growth
- NRXP N/A
- LVTX 77.01
- 52 Week Low
- NRXP $1.10
- LVTX $0.85
- 52 Week High
- NRXP $6.01
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- NRXP 53.92
- LVTX 57.94
- Support Level
- NRXP $1.85
- LVTX $1.03
- Resistance Level
- NRXP $2.10
- LVTX $1.44
- Average True Range (ATR)
- NRXP 0.16
- LVTX 0.09
- MACD
- NRXP 0.04
- LVTX 0.02
- Stochastic Oscillator
- NRXP 90.18
- LVTX 73.55
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.